Ogalvibart, CAS 2599039-60-6

Product Description: Ogalvibart (C-135-LS) is a human anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Ogalvibart binds to the spike (S) glycoprotein receptor-binding domain (RBD) of SARS-CoV-2. Ogalvibart in combination with C144LS (1:1 ratio) shows good preventive activity and can effectively block the development of COVID19 in a rhesus monkey disease model[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Beddingfield BJ, et al. Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing Antibodies. Front Cell Infect Microbiol. 2021 Nov 18;11:753444.

CAS Number: 2599039-60-6

Molecular Weight: N/A

Research Area: Infection

Solubility: 10 mM in DMSO

Target: SARS-CoV

• SKU: MEXHY-145644-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-145644-1
• Green Labware: No
• Package Unit: 1mg
• Quantity Unit: STK